Expertise

Clinical psychiatry; psychopathology; psychosis; neuropsychiatry; neuroimaging; structural magnetic resonance imaging; psychopharmacology; antipsychotics; side-effects of antipsychotic medication

Primære forskningsområder

Multimodal cohort studies on antipsychotic-naïve patients with first episode psychosis, with particular focus on structural and neurochemical brain changes after antipsychotic treatment; Physiological effects of GLP-1 analogue treatment of obesity in schizophrenia patients

Aktuel forskning

Multimodal- and multivariate analyses of first episode antipsychotic naive patients; studies on metabolic side-effects of antipsychotic medication; diffusion tensor imaging (DTI) studies on patients at high risk for psychosis and first episode patients; studies on physiological effects of GLP-1 analogue treatment of obesity in schizophrenia patients (a randomized controlled trial)

Mulige interessekonflikter

Lecture fees and/or is part of Advisory Boards of Bristol-Myers Squibb, Eli Lilly and Company, Janssen-Cilag, Otsuka Pharma Scandinavia and Takeda Pharmaceutical Company